OwlTail

Cover image of Ethan Russo

Ethan Russo

37 Podcast Episodes

Latest 1 Oct 2022 | Updated Daily

Episode artwork

Minor Cannabinoids with Dr. Ethan Russo

Professionally Cannabis & Psychedelics

Today’s episode will be slightly different to the norm… Having received a few notes from newer listeners keen to understand more about individual cannabinoids, I thought it would be cool this week to play out a session that ran last year at the GCI Summit with none other than Dr. Ethan Russo.  As one of the modern-day OGs of cannabis research and science, it is always a pleasure to pick the brain of Ethan, who is an unequivocal authority on the plant and its constituent parts. As a heads up, the session was initially recorded on Zoom, so the audio quality will be slightly different to the typical pods; however, I hope that hearing the wonderful insights of Dr. Russo will be enough of an audio feast for you!Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/ 

28mins

23 Jun 2022

Episode artwork

#65: Dr. Mike Hart and Ethan Russo, MD

Hart2Heart with Dr. Mike Hart

Ethan Russo, MD, is known as the godfather of cannabis. He is a board-certified neurologist, psychopharmacology researcher, and author. He is also the Founder and CEO of credo-science.com. Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic.In this podcast, we discuss why Sativa vs. Indica nomenclature needs to be phased out, "the entourage effect," the specific clinical applications of THCV, CBN, CBG, and how to use terpenes to enrich your cannabis experience.

57mins

23 Jun 2022

Similar People

Episode artwork

Episode 97 The Importance of Terpenes and the Entourage Effect with Dr. Ethan Russo

Cannabis Cultivation and Science Podcast

Dr. Russo is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of credo-science.com.   He graduated from the University of Pennsylvania (Psychology), and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula, Montana for 20 years in a practice with a strong chronic pain component. In 1995, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu, Peru. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences, Harvard University, and Johns Hopkins University. He has also published numerous book chapters, and over fifty articles in neurology, pain management, cannabis, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms, phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and phytocannabinoid/terpenoid, serotonergic and vanilloid interactions. He has consulted or lectured on these topics in 39 US states and Canadian provinces and 39 countries.

54mins

9 Jun 2022

Episode artwork

Coffee Talk Live from CannMed 2022 Part 1 with Ethan Russo, Eloise Theisen, and Bonni Goldstein

CannMed Coffee Talk

CannMed 2022 is officially in the books. Thank you to all our attendees, presenters, sponsors, exhibitors, media partners, and team members behind the scenes who make it all possible. It was great to see everyone in person again and learn about the latest advancements in the field. We discussed novel cannabinoids, new treatment protocols, exciting new advances in breeding and cultivation, stronger safety testing methods and of course, the latest advances in our understanding and use of medicinal mushrooms. We also had the chance to record interviews with some of our presenters in the CannMed Coffee Talk Lounge that we had set up at the venue. Today’s episode will feature three of those conversations. The first is with Science Keynote presenter Ethan Russo, MD. The second is with presenter and medical practicum instructor Eloise Theisen, NP. And last but certainly not least is Medicine Keynote, Medical Practicum Instructor, and CannMed staple Bonni Goldstein, MD.  Each conversation is 10-15 minutes long and we talk about the value of in-person meetings, such as CannMed, as well as details about each of their presentations. Thanks to This Episode’s Sponsor: Medicine Women Health Medicine Women’s team of specialists includes Medical Doctors, Naturopaths, Medical Cannabis Experts, Nutritionists and Alternative Health Practitioners. These integrative teams evaluate health issues and design targeted protocols to promote personal healing. Medicine Women’s Protocols have successfully alleviated symptoms of Cancer, Auto-Immune Diseases and Neurological Conditions, as well as providing overall Health Rejuvenation. Learn more at medicinewomenhealth.com. Additional Resources CannMed Coffee Talk Lounge Videos CannMed Archive CannMed Community Board [Facebook Group] Healthcare Provider Medical Cannabis Research Study

35mins

11 May 2022

Most Popular

Episode artwork

Nishi Whitely, Mojave Richmond, Ethan Russo, MD, from Breeder’s Best

Cannabis Talk 101

Nishi Whitely, Mojave Richmond from Breeder’s Best. They work with breeders to license their patented cultivars in markets worldwide. Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of credo-science.com. See omnystudio.com/listener for privacy information.

51mins

6 May 2022

Episode artwork

Reviewing Research on Cannabis and COVID-19 with Ethan Russo, MD

CannMed Coffee Talk

Dr. Ethan Russo returns to the podcast to help us make sense of the slew of studies and articles claiming cannabis can treat and/or prevent COVID-19 infection. Dr. Russo is a board-certified neurologist, a psychopharmacology researcher, an author, a lecturer, and a consultant. He is a CannMed 2022 Keynote Presenter, where he will present on Cannabis and Psychiatry. Although Dr. Russo is not a virologist, he is a very accomplished medical cannabis researcher, and he is well-qualified to help us find the signal in all the noise. During the conversation, we discuss: What role the endocannabinoid system plays in preventing and clearing a viral infection The different levels of clinical research The importance of peer review process The University of Chicago study that claims CBD inhibits SARS-CoV-2 replication The Oregon University Study that claims cannabinoid acids can prevent covid infection Animal models showing CBD can calm the cytokine storm A preprint study claiming CBD primes the innate immune system Claims that cannabis smokers have a greater risk for COVID-19 infection Thank You to This Episode’s Sponsor: Project CBDFounded in 2010, Project CBD is the first and longest-running website dedicated to research and education on the benefits of CBD, and the premier destination for both curious and committed CBD consumers. Often the first to report on cutting-edge health issues, Project CBD reporting reflects a deeper understanding of developments in cannabinoid science and therapeutics.Learn more at ProjectCBD.com Additional ResourcesCannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesCannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging VariantsEvaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of AsthmaIn search of preventive strategies: novel high-CBD Cannabis sativa extracts modulate ACE2 expression in COVID-19 gateway tissuesCannMed ArchiveCannMed Community Board [Facebook Group]Healthcare Provider Medical Cannabis Research Study

36mins

2 Feb 2022

Episode artwork

099 Ethan Russo - Meeting the mother of cannabinoids

The LabAroma Podcast by Colleen Quinn

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of CReDo Science www.credo-science.com In this episode, Dr. Ethan Russo talks to us about his new study on CBG, ‘the mother of all cannabinoids’, cannabinoid acids, and affordable diagnostics for the endocannabinoid system that provide needed information for patients and doctors. This technology could improve outcomes and product choices for all phyto-therapies, such as aromatherapy, herbalism, and cannabinoid therapy, which Dr. Russo believes can be much more nimble than one-size-fits-all pharmaceuticals in addressing the individualized needs of the patient. Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic: https://www.icci.science. Medical Director of PHYTECS (2015-2017), a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (http://www.phytecs.com), and from 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy (https://www.gwpharm.com). He graduated from the University of Pennsylvania (Psychology), and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula, Montana for 20 years in a practice with a strong chronic pain component. In 1995, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu, Peru. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences, Harvard University, and Johns Hopkins University. He is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs, co-editor of Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS, Women and Cannabis: Medicine, Science and Sociology, Cannabis: From Pariah to Prescription, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters, and over sixty articles in neurology, pain management, cannabis, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms, phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and phytocannabinoid/terpenoid, serotonergic and vanilloid interactions. He has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.Useful Links:https://credo-science.com/projects/CBG StudyCReDoEndo DNA testsEurofins worldwide testinghttps://ethanrusso.org/category/library/ To learn more about plants & your health from Colleen at LabAroma check out this informative PDF: https://mailchi.mp/2fe0e426b244/osw1lg2dkhDisclaimer: The information presented in this podcast is for educational purposes only and is not intended to replace professional medical advice. Please consult your doctor if you are in need of medical care, and before making any changes to your health routine.

44mins

19 Oct 2021

Episode artwork

BTS #62 Ethan Russo MD on a New Understanding of Cannabinoid Hyperemesis Syndrome

The Curious About Cannabis Podcast

In this behind-the-scenes conversation, we are joined once again by cannabinoid researcher Dr. Ethan Russo. Russo and a team of researchers recently published a research paper entitled, “Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation” which announced findings that could help explain the physiology of CHS, provide tools for screening Cannabis users for CHS, and lead to the development of targeted treatments for CHS. Throughout our conversation Dr. Russo explains what CHS is, how it compares to Cyclical Vomiting Syndrome, common misunderstandings about CHS, the results of his recent research study, and what we might expect from the future of CHS research. Read the study: https://pubmed.ncbi.nlm.nih.gov/34227878/ Learn more about CReDO Science: www.credo-science.com Stay curious!

59mins

3 Aug 2021

Episode artwork

EPISODE #120 Cannabinoid Hyperemesis Syndrome with Dr. Ethan Russo, Founder of Credo Science

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

What is Cannabinoid Hyperemesis Syndrome (CHS)?This week, we welcome back Dr. Ethan Russo, physician, researcher, and leading expert in the field of Medicinal Cannabis. In this episode, Dr Russo shares the latest research and findings of the largest study on CHS to date - in which his team identified 6 potential genetic targets to assist in the diagnosis and treatment of the condition.→ View full show notes, summary, and access resources here: https://www.canverse.global/shownotes/e120About Dr. Ethan RussoEthan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.ResourcesJoin Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_RussoCReDO Science Website: https://credo-science.com/Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation Paper: https://pubmed.ncbi.nlm.nih.gov/34227878/

36mins

8 Jul 2021

Episode artwork

Cannabinoid Hyperemesis Syndrome Genomic Investigation Results with Dr. Ethan Russo

Shaping Fire

Today, Dr. Ethan Russo has published his groundbreaking research into the causes of Cannabis Hyperemesis Syndrome. The research team's survey and genomic investigation of patients has, for the first time, identified the genetic mutations affecting neurotransmitters and the endocannabinoid system. In this episode of Shaping Fire, host Shango Los reviews the entirety of the paper with Dr. Russo, including all five of the genetic mutations, the results of the patient survey and why we can exclude causes such as neem.

1hr 28mins

6 Jul 2021

Loading